Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
4
×
boston blog main
boston top stories
life sciences
national blog main
4
×
national top stories
new york blog main
cancer
clinical trials
national
new york top stories
san francisco blog main
san francisco top stories
autoimmune diseases
biotech ipos
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
detroit blog main
detroit top stories
europe blog main
europe top stories
fda
immunotherapy
indiana blog main
indiana top stories
investing
medicare
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abeona therapeutics
accent therapeutics
What
market
4
×
patients
drug
medicine
new
advantages
arrival
bar
benefiting
bio
biotech
boston
brings
cancer
coming
companies
days
diagnostics
eisai
expect
fda
flags
gamble
glimcher
groundbreaking
hasn’t
headline
higher
incidence
industry
ipo
ipos
keynote
laurie
life
lorcaserin
loss
marketing
medco’s
momentum
Language
unset
Current search:
market
×
biotech
×
" national blog main "
×
@xconomy.com
3 years ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@xconomy.com
4 years ago
Eisai Pulls Weight Loss Drug From Market After FDA Flags Cancer Risks
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
4 years ago
Laurie Glimcher To Headline Xconomy Keynote Series in Boston in September